CBLL — Ceribell, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1861107 ·
Last close
$18.80
Market Cap
$713.32M
52W High
$21.65
52W Low
$15.84
ADV30
320,047
Next earnings
2026-08-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 26,494,000 | 23,122,000 | -20,745,000 | -19,737,000 | 178,078,000 | 45,252,000 | 37,265,000 |
| Dec 2025 | 24,784,000 | 21,643,000 | -14,596,000 | -13,527,000 | 195,803,000 | 40,476,000 | 40,467,000 |
| Sep 2025 | 22,589,000 | 19,942,000 | -14,647,000 | -13,465,000 | 199,525,000 | 23,739,000 | 35,444,000 |
| Jun 2025 | 21,199,000 | 18,682,000 | -14,952,000 | -13,643,000 | 207,689,000 | 40,141,000 | 35,534,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-40,808,000
Investing CF
$-118,137,000
Financing CF
$5,051,000
CapEx
$-1,184,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.47
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-220,356,000
Inventory
$7,288,000
Receivables
$15,053,000
ST Investments
$118,785,000
EBIT TTM
$-51,522,000
Pretax Income TTM
$-53,412,000
Interest Exp TTM
$1,890,000
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$95,066,000
EBITDA
$-63,695,000
Free Cash Flow
$-29,333,624
Enterprise Value
$593,116,480
Total Cash
$141,184,000
Total Debt
$22,116,000
Shares Out
37,942,700
Trailing EPS
$-1.62
Book Value
$3.72
ROE
-37.5%
ROA
-20.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 89,063,000 | -58,402,000 | -53,412,000 | 195,803,000 | 40,467,000 | — | -40,808,000 |
| Dec 2024 | 65,444,000 | -39,709,000 | -40,455,000 | 225,412,000 | 34,247,000 | — | -35,043,000 |
| Dec 2023 | 45,225,000 | -30,041,000 | -29,464,000 | 58,922,000 | 171,174,000 | — | -29,159,000 |
| Dec 2022 | 25,922,000 | -36,021,000 | -37,164,000 | 86,458,000 | 172,856,000 | — | -32,002,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.10
Max Pain — expiry 2026-06-18
max pain strike: $17.50 · spot: $18.80 · call oi: 969 · put oi: 45
Expected Move to 2026-06-18:
±$2.48
(13.16%) —
implied range
$16.32 –
$21.27
· ATM straddle on $20.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SGP | SpyGlass Pharma, Inc. | $689.40M | $20.62 | — |
| SSII | SS Innovations International, Inc. | $746.49M | $3.73 | — |
| BRSYF | Brainsway Ltd. | $674.45M | $16.84 | — |
| SIBN | SI-BONE, Inc. | $650.60M | $14.67 | — |
| BWAY | Brainsway Ltd. | $636.40M | $15.89 | — |
News headlines (Yahoo Finance, 1h cache)
Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference
2026-05-20 20:05 · Yahoo
CeriBell Sees ‘Early Innings’ Growth as Hospital Accounts and Usage Hit Records
2026-05-15 05:07 · Yahoo
CeriBell Inc (CBLL) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Market ...
2026-05-12 07:07 · Yahoo
CeriBell Q1 Earnings Call Highlights
2026-05-11 23:05 · Yahoo
CeriBell (CBLL) Q1 2026 Earnings Transcript
2026-05-11 22:07 · Yahoo
CeriBell, Inc. (CBLL) Reports Q1 Loss, Beats Revenue Estimates
2026-05-11 22:05 · Yahoo
Ceribell Reports First Quarter 2026 Financial Results
2026-05-11 20:05 · Yahoo
Phibro Animal Health (PAHC) Q3 Earnings and Revenues Surpass Estimates
2026-05-06 22:30 · Yahoo
Ceribell to Participate in the Bank of America Securities 2026 Health Care Conference
2026-04-29 20:05 · Yahoo
Ceribell to Report First Quarter 2026 Financial Results on May 11, 2026
2026-04-20 20:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.